First publication PROTID


In the IJTLD article “Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis’’, Professor Anthony Harries made a plea for studies to assess the value of targeted preventative therapy among people with diabetes.

The PROTID investigators responded that their first global randomised controlled trial will address that very issue; evaluating the efficacy and potential impact of preventive treatment of latent tuberculosis infection (LTBI) targeted at people living with Diabetes Mellitus (DM).

For the full article visit this page.